Multicenter Cohort Study of AAV in Hunan of China

This study aimed to explore the incidence of Anti-neutrophil cytoplasmic antibody (ANCA）-associated vasculitis (AAV) progression and its association with adverse consequences. It will enroll approximately 500 AAV patients in Hunan province of China and follow-up for at least 5 years. Demographic characteristics, clinical and laboratory data will be collected at baseline and every follow-up. The principal clinical outcomes of the study consist of end stage renal disease (ESRD) and death.

NCT Number	NCT05315141
Lead Sponsor	Xiangya Hospital of Central South University Collaborators: Central South University, The Third Xiangya Hospital of Central South University, Hunan Provincial People's Hospital, Xiangtan Central Hospital
Conditions	ANCA Associated Vasculitis
Enrollment	500 participants
Start Date	2022-03-16
Primary Completion	2027-03-16 (estimated)
Study Completion	2027-03-16 (estimated)
Updated on ClinicalTrials.gov	2022-04-07